vildagliptin and its Impurities

Vildagliptin is used in combination to treat Diabetes Mellitus Type 2. Vildagliptin is an oral anti-hyperglycemic agent. Reference standards of Vildagliptin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 11 results for vildagliptin Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 22 0171055

1,1',1''-(2,2',2''-Nitrilotris(acetyl))tris(pyrrolidine-2-carbonitrile)

1,1',1''-(2,2',2''-Nitrilotris(acetyl))tris(pyrrolidine-2-carbonitrile)


  • Catalogue No.:PA 22 0171055

  • CAS :

    NA

  • Molecular Formula : C21H27N7O3

  • Molecular Weight : 425.49

Drug Reference Standards & Impurity Synthesis in India
PA 22 0171056

(R)-2-((1r,3S,5R,7S)-3-Hydroxyadamantan-1-yl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione

(R)-2-((1r,3S,5R,7S)-3-Hydroxyadamantan-1-yl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione


  • Catalogue No.:PA 22 0171056

  • CAS :

    NA

  • Molecular Formula : C17H24N2O3

  • Molecular Weight : 304.39

Drug Reference Standards & Impurity Synthesis in India
PA 22 0171057

Methyl N-((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)-N-nitrosoglycyl-L-prolinate

Methyl N-((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)-N-nitrosoglycyl-L-prolinate


  • Catalogue No.:PA 22 0171057

  • CAS :

    NA

  • Molecular Formula : C18H27N3O5

  • Molecular Weight : 365.43

Drug Reference Standards & Impurity Synthesis in India
PA 22 0171058

Methyl L-prolinate

Methyl L-prolinate


  • Catalogue No.:PA 22 0171058

  • CAS :

    2577-48-2

  • Molecular Formula : C6H11NO2

  • Molecular Weight : 129.16

Drug Reference Standards & Impurity Synthesis in India
PA 22 0171059

Ethyl L-prolinate

Ethyl L-prolinate


  • Catalogue No.:PA 22 0171059

  • CAS :

    5817-26-5

  • Molecular Formula : C7H13NO2

  • Molecular Weight : 143.19

Drug Reference Standards & Impurity Synthesis in India
PA 22 0171060

(3-Hydroxyadamantan-1-yl)glycylproline

(3-Hydroxyadamantan-1-yl)glycylproline


  • Catalogue No.:PA 22 0171060

  • CAS :

    NA

  • Molecular Formula : C17H26N2O4

  • Molecular Weight : 322.41

Drug Reference Standards & Impurity Synthesis in India
PA 22 0171061

1-(2-Chloroacetyl)pyrrolidine-2-carboxamide

1-(2-Chloroacetyl)pyrrolidine-2-carboxamide


  • Catalogue No.:PA 22 0171061

  • CAS :

    94747-48-5

  • Molecular Formula : C7H11ClN2O2

  • Molecular Weight : 190.63

Drug Reference Standards & Impurity Synthesis in India
PA 22 0171062

(S)-1-(((1r,3R,5S,7S)-3,5-dihydroxyadamantan-1-yl)glycyl)pyrrolidine-2-carbonitrile

(S)-1-(((1r,3R,5S,7S)-3,5-dihydroxyadamantan-1-yl)glycyl)pyrrolidine-2-carbonitrile


  • Catalogue No.:PA 22 0171062

  • CAS :

    NA

  • Molecular Formula : C17H25N3O3

  • Molecular Weight : 319.41

Drug Reference Standards & Impurity Synthesis in India
PA 22 0171063

2-((1S,3R,5R)-3-Hydroxyadamantan-1-yl)-2,3,6,8a-tetrahydropyrrolo[1,2-a]pyrazine-1,4-dione

2-((1S,3R,5R)-3-Hydroxyadamantan-1-yl)-2,3,6,8a-tetrahydropyrrolo[1,2-a]pyrazine-1,4-dione


  • Catalogue No.:PA 22 0171063

  • CAS :

    NA

  • Molecular Formula : C17H22N2O3

  • Molecular Weight : 302.37

Drug Reference Standards & Impurity Synthesis in India
PA 22 0171064

4-Hydroxy-2-((1r,3s,5R,7S)-3-hydroxyadamantan-1-yl)-6,7-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one

4-Hydroxy-2-((1r,3s,5R,7S)-3-hydroxyadamantan-1-yl)-6,7-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one


  • Catalogue No.:PA 22 0171064

  • CAS :

    NA

  • Molecular Formula : C17H22N2O3

  • Molecular Weight : 302.37

Drug Reference Standards & Impurity Synthesis in India
PA 22 0171065

6,6',7,7',8,8a,8',8'a-Octahydro-[3,3'-bipyrrolo[1,2-a]pyrazine]-1,1',4,4'-tetraone

6,6',7,7',8,8a,8',8'a-Octahydro-[3,3'-bipyrrolo[1,2-a]pyrazine]-1,1',4,4'-tetraone


  • Catalogue No.:PA 22 0171065

  • CAS :

    NA

  • Molecular Formula : C14H14N4O4

  • Molecular Weight : 302.29

pharmaffiliates